Initial public offering of Alligator Bioscience AB (SE) on Nasdaq Stockholm – SEK 483 million

Carnegie acted as sole global co-ordinator in the initial public offering of Alligator on Nasdaq Stockholm. Alligator is a research-based biotechnology company that develops innovative immune activating antibody drugs for tumor-directed immunotherapy. November 2016.